DEFA14A: Masimo's Proxy Battle Heats Up: Founder Faces Ouster Amidst Shareholder Activism

A high-stakes proxy battle at Masimo, pitting founder Joe Kiani against activist investor Quentin Koffey, culminates in a shareholder vote that could determine the company's future leadership and direction.

Summary

• This document discusses the ongoing proxy battle at Masimo between founder and CEO Joe Kiani and activist investor Quentin Koffey of Politan Capital Management.
• The conflict stems from Masimo's acquisition of Sound United in 2022, which led to a significant drop in the company's stock price and attracted Koffey's attention.
• Koffey believes Kiani has too much control over the company, while Kiani accuses Koffey of being duplicitous and lacking a concrete plan.
• Shareholders will vote on September 19, 2024, to determine whether Kiani will retain his board seat.
• Kiani has vowed to leave the company if Koffey wins, and Masimo's COO has threatened to quit as well.
• The article highlights the increasing prevalence of shareholder activism and the challenges it poses for corporate boards.
• The proxy fight has been acrimonious, with both sides accusing each other of misstatements and omissions.
• Masimo's core business revolves around noninvasive patient monitoring, particularly pulse oximetry, and the company has been involved in intellectual property disputes with Apple.
• The document also includes forward-looking statements and cautions investors about the risks and uncertainties associated with the proxy battle.

Sentiment

Score: 4

Explanation: The document highlights significant conflict and uncertainty surrounding Masimo's leadership and future direction, leading to a negative sentiment.

Positives

• Masimo has a long track record of success in the medical device industry.
• The company's technology is used by about 200 million people in hospitals and homes worldwide.
• Masimo has a strong patent portfolio and has been a leader in noninvasive patient monitoring.
• Masimo is a $2-billion-a-year company with steady earnings.

Negatives

• The acquisition of Sound United was unpopular with shareholders and led to a significant drop in the company's stock price.
• The proxy battle has created uncertainty and disruption within the company.
• Key personnel, including the CEO and COO, have threatened to leave if certain outcomes occur.
• The company has been involved in a high-profile intellectual property dispute with Apple.

Risks

• The outcome of the proxy battle is uncertain and could lead to significant changes in the company's leadership and direction.
• The departure of key personnel could negatively impact the company's operations and innovation.
• The intellectual property dispute with Apple could have financial and reputational consequences.
• Shareholder activism could continue to be a distraction for the company.

Future Outlook

The future of Masimo is uncertain, depending on the outcome of the proxy vote and the potential departure of key personnel. The company is exploring separating its consumer business.

Management Comments

• Joe Kiani: 'To me, the possibilities were compelling.'
• Joe Kiani: 'I believe were going to win this thing. Im not some mad entrepreneur who wants to do things a certain way. I want to do whats good for my company. I think consumer health is the future of health care and I want us to be there. I hope I dont have to leave this. I have a succession plan. The problem is, if he wins, the succession plan would leave with me. Theyre not going to want to stay and its going to be a disaster.'
• Bilal Muhsin: 'Im responsible for everything in the healthcare division, right from sales to operations to engineering, adding that its an honor to have played such a critical role in a company that saves lives.'
• Bilal Muhsin: 'I wanted to be honest with investors; I didnt want it to come as a surprise to them.'
• Bilal Muhsin: 'If the board that comes on is similar to the last round, where they sided together and decided not to engage, I dont know. If Joe decides to leave on his own, he would leave behind a legacy of people to execute this place would continue and thrive.'
• Bilal Muhsin: 'If Koffey succeeds in adding new directors and Kiani leaves, though, Muhsin says, I dont believe that is a bright future thats going to lead to more innovation and benefit the company If that does take place, I will most likely not be here.'

Industry Context

The Masimo situation reflects a broader trend of increased shareholder activism, particularly following the SEC's implementation of the universal proxy card rule. This rule makes it easier for dissident shareholders to challenge corporate boards.

Comparison to Industry Standards

• Masimo's battle with Apple over intellectual property is similar to other cases where established medical device companies have clashed with tech giants entering the healthcare space.
• The proxy fight mirrors situations at companies like Procter & Gamble where activist investors have sought board representation to influence strategy.
• The potential separation of Masimo's consumer business echoes moves by companies like Johnson & Johnson to streamline operations and focus on core healthcare segments.

Legal Proceedings

• Masimo filed a lawsuit against Politan to correct material misstatements and omissions.
• Masimo has been involved in an intellectual property dispute with Apple, which resulted in a mistrial but a separate ruling by the U.S. International Trade Commission (ITC) found that Apple did infringe one patent.

Stakeholder Impact

• Shareholders face uncertainty regarding the company's future direction and stock performance.
• Employees are concerned about potential changes in company culture and leadership.
• Customers may be affected by any disruptions to Masimo's operations or product development.
• The outcome of the proxy battle could impact Masimo's relationships with suppliers and partners.

Next Steps

• Shareholders will vote on September 19, 2024, to determine the composition of Masimo's board of directors.
• The company will continue to pursue its intellectual property dispute with Apple.
• Masimo will explore separating its consumer business.

Key Dates

Keywords

Masimo, proxy battle, shareholder activism, Joe Kiani, Quentin Koffey, Politan Capital Management, Sound United, corporate governance, activist investor, board of directors